川投能源(600674.SH):屏山抽水蓄能電站項目市場化競爭配置投資開發主體優選結果確認
格隆匯11月1日丨川投能源(600674.SH)公佈,公司於2023年6月28日披露了《關於屏山抽水蓄能電站項目市場化競爭配置投資開發主體優選(第二次)評審結果公示的提示性公吿》,確定了四川川投能源股份有限公司、雅礱江流域水電開發有限公司、中國葛洲壩集團股份有限公司聯合體為屏山抽水蓄能電站項目市場化競爭配置投資開發主體優選(第二次)工作的第一名。2023年11月1日,公司收到屏山縣人民政府發出的《投資開發主體確認書》,確定聯合體為屏山抽水蓄能電站項目投資開發主體。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.